MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

Search

NeoGenomics Inc

Open

8.97 5.53

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.45

Max

9.07

Belangrijke statistieken

By Trading Economics

Inkomsten

-19M

-45M

Verkoop

13M

181M

Winstmarge

-24.867

Werknemers

2,200

EBITDA

-41M

-48M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+22.36% upside

Dividenden

By Dow Jones

Volgende Winsten

4 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

172M

1B

Vorige openingsprijs

3.44

Vorige sluitingsprijs

8.97

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

NeoGenomics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 sep 2025, 14:35 UTC

Belangrijke Marktbewegers

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

25 sep 2025, 16:56 UTC

Belangrijke Marktbewegers

PSQ Holdings Stock Slides on Plans to Launch Crypto Treasury Service

25 sep 2025, 16:31 UTC

Belangrijke Marktbewegers

SharpLink Gaming Shares Fall on Plan to Tokenize Stock

25 sep 2025, 08:03 UTC

Belangrijke Marktbewegers

Naver Surges on Talks With Cryptocurrency-Exchange Operator

23 sep 2025, 18:02 UTC

Belangrijke Marktbewegers

Super League Shares Double After $10 Million Equity Investment From Evo Fund

23 sep 2025, 13:09 UTC

Acquisities, Fusies, Overnames

Innovation Beverage Strikes Deal to Merge Into BlockFuel Energy

22 sep 2025, 17:33 UTC

Belangrijke Marktbewegers

AgriFORCE Growing Systems Shares Double on New Blockchain Strategy

2 okt 2025, 13:17 UTC

Acquisities, Fusies, Overnames

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2 okt 2025, 13:16 UTC

Acquisities, Fusies, Overnames

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2 okt 2025, 13:16 UTC

Acquisities, Fusies, Overnames

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2 okt 2025, 13:15 UTC

Acquisities, Fusies, Overnames

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2 okt 2025, 07:05 UTC

Marktinformatie

Global Equities Roundup: Market Talk

2 okt 2025, 07:05 UTC

Marktinformatie

Bitcoin Rises Following Wall Street Rally -- Market Talk

1 okt 2025, 23:12 UTC

Acquisities, Fusies, Overnames

Avalanche Treasury CEO is Bart Smith

1 okt 2025, 23:11 UTC

Acquisities, Fusies, Overnames

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

1 okt 2025, 23:07 UTC

Acquisities, Fusies, Overnames

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

1 okt 2025, 23:06 UTC

Acquisities, Fusies, Overnames

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

1 okt 2025, 23:04 UTC

Acquisities, Fusies, Overnames

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

1 okt 2025, 14:01 UTC

Marktinformatie

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

1 okt 2025, 07:27 UTC

Marktinformatie

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

30 sep 2025, 14:20 UTC

Belangrijke Marktbewegers

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

30 sep 2025, 06:51 UTC

Marktinformatie

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

29 sep 2025, 13:48 UTC

Marktinformatie

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

29 sep 2025, 07:40 UTC

Marktinformatie

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

26 sep 2025, 07:29 UTC

Marktinformatie

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

25 sep 2025, 09:16 UTC

Marktinformatie

Bitcoin Falls as Investors Await U.S. Data -- Market Talk

24 sep 2025, 12:50 UTC

Acquisities, Fusies, Overnames

Fitell Corp Completes Initial $10M Solana Purchase Following the First Closing Under $100M Financing Facility

24 sep 2025, 06:55 UTC

Marktinformatie

Bitcoin Stays Weak After Powell Remarks -- Market Talk

23 sep 2025, 17:47 UTC

Belangrijke Marktbewegers

Super League Shares Double After $10M Equity Investment From Evo Fund

22 sep 2025, 20:36 UTC

Acquisities, Fusies, Overnames

Scaramucci-Backed Crypto Treasury Company Launches With $550 Million Fundraising Plan -- Update

Peer Vergelijking

Prijswijziging

NeoGenomics Inc Prognose

Koersdoel

By TipRanks

22.36% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 10.67 USD  22.36%

Hoogste 14 USD

Laagste 8 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor NeoGenomics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

5

Buy

6

Hold

0

Sell

Technische score

By Trading Central

7.7 / 10.27Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat